$ALTO

Alto Ingredients, Inc. (ALTO): Results of Operations and Financial Condition

Alto Ingredients, Inc. (ALTO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Alto Ingredients, Inc. Reports Second Quarter 2026 Results Q2 2026 Gross Profit of $16.6 Million Increased $18.6 Million Q2 2026 Net Income of $11.4 Million, or $0.15 per Share, Improved $22.7 Million Q2 2026 Adjusted EBITDA of $23.7 Million Improved $23.9 Million Pe

Original reporting
Published Aug 5, 2026, 8:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 8:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ALTO
Bullish
medium confidence
Mentioned
$ALTO
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ALTOBullishMed
01

Why it matters

The earnings section provides fresh, period-specific profitability metrics, while the ATM announcement is a new financing catalyst that can affect valuation via dilution expectations and funding capacity for capacity and CO2 optimization initiatives.

02

Market read

Traders can update models for near-term profitability and reassess dilution risk and funding flexibility from the newly established ATM program.

03

What to watch

Adjusted EBITDA excludes items and the release emphasizes 45Z tax credits; traders may discount sustainability if credit economics or utilization assumptions change.

Relevance 7/10Novelty 8/10Timing: after-hours filing today, Aug 5, 2026

Background

This is an SEC Form 8-K with Exhibit 99.1 reporting Alto’s Q2 2026 financial results and announcing a new $50M at-the-market equity program.

Company-level read

Ticker impact

$ALTOBullishMedium confidence
Context

Alto reported Q2 2026 results with net income of $11.4M and established a $50M at-the-market equity program.

Expected impact

Likely positive bias initially on earnings strength, with potential sell-the-news or volatility tied to expectations for ATM usage.

Evidence & confidence

The filing discloses both a concrete earnings datapoint (gross profit, net income, adjusted EBITDA) and a fresh financing tool (ATM $50M). The net effect depends on how investors expect the company to deploy the ATM and whether dilution concerns outweigh growth/capex plans.

Market effects

Renewable fuels and specialty alcohol producers may see read-across interest in profitability durability and tax-credit monetization (45Z) versus commodity cycles.

Limited, as the disclosure is company-specific and not a regional macro event.

Low, as the news is not tied to global supply shocks or international regulatory actions.

Counterpoint

The ATM program can cap upside if investors expect meaningful share issuance before returns materialize, despite strong current-quarter profitability.

Key entities

  • Alto Ingredients, Inc.

    NASDAQ-listed renewable fuels and specialty alcohols producer reporting Q2 2026 results and launching a $50M ATM program.

  • Bryon McGregor

    President and CEO cited on diversification strategy and confidence in sustainable earnings.

  • Rob Olander

    CFO cited the $50M ATM program as a low-cost equity capital tool.

Related articles

$ALTOMedAI 9/10

Alto (ALTO) Q2 2026 Earnings Call Transcript

Alto Ingredients (ALTO) reported Q2 2026 results in an earnings call. Net sales rose to $245.7M, adjusted EBITDA was $23.7M, and net income attributable to common stockholders was $11.4M ($0.15/diluted share). Full-year Section 45Z guidance is $15M to $16M. Management discussed capacity expansion, CO2 storage, and a $50M at-the-market equity program.

$UNFIMedAI 8/10

United Natural Foods (UNFI) Calls the Bottom and Guides for Growth Again

United Natural Foods (UNFI) reported Q4 adjusted EPS of $0.69, beating estimates, but revenue of $7.64B missed expectations. The company guided fiscal 2027 sales to $31.2B-$31.8B, up from $31.15B in 2026. Adjusted EBITDA rose 27% to $701M, and free cash flow hit a record $323M. Management expects fiscal 2027 adjusted EPS of $3.00-$3.50. Hedge fund interest declined in Q2.

MedAI 8/10

LuxExperience B.V. Q4 2026 Earnings Call Summary

LuxExperience B.V. reported Q4 2026 earnings, highlighting EBITDA break-even 15 months post-acquisition. Mytheresa reached EUR 1 billion in sales, while NET-A-PORTER and MR PORTER returned to growth. YOOX cut losses by half. Management expects 2%-3% EBITDA margins in FY 2027 and EUR 4 billion in net sales by 2028. The company improved operational efficiency and strengthened its financial position.

$MOVMed

Movado’s Turnaround Gains Momentum

Movado Group (NYSE: MOV) reported two consecutive quarters of earnings beats, with shares up 60% year-to-date. Analysts rate it a Strong Buy, with an average price target of $40, implying 22% upside. The company benefited from tariff refunds and a shift in consumer preferences toward traditional watches. However, investors should consider potential margin pressures and competition from smartwatches.